de Groot ER - Search Results

1

Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis.

Gerards AH, de Lathouder S, de Groot ER, Dijkmans BA, Aarden LA. Gerards AH, et al. Among authors: de lathouder s, de groot er. Rheumatology (Oxford). 2003 Oct;42(10):1189-96. doi: 10.1093/rheumatology/keg323. Epub 2003 May 30. Rheumatology (Oxford). 2003. PMID: 12777636

2

Mycophenolic acid and methotrexate inhibit lymphocyte cytokine production via different mechanisms.

de Lathouder S, Gerards AH, de Groot ER, Valkhof M, Aarden LA. de Lathouder S, et al. Among authors: de groot er. Eur Cytokine Netw. 2002 Jul-Sep;13(3):317-23. Eur Cytokine Netw. 2002. PMID: 12231475 Free article.

3

Bioassay for detection of methotrexate in serum.

de Lathouder S, Gerards AH, de Groot ER, Valkhof MG, Dijkmans BA, Aarden LA. de Lathouder S, et al. Among authors: de groot er. Scand J Rheumatol. 2004;33(3):167-73. doi: 10.1080/03009740310004865. Scand J Rheumatol. 2004. PMID: 15228187 Clinical Trial.

4

Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti-infliximab in responders and non-responders to therapy for rheumatoid arthritis.

van der Laken CJ, Voskuyl AE, Roos JC, Stigter van Walsum M, de Groot ER, Wolbink G, Dijkmans BA, Aarden LA. van der Laken CJ, et al. Among authors: de groot er. Ann Rheum Dis. 2007 Feb;66(2):253-6. doi: 10.1136/ard.2006.057406. Epub 2006 Jun 22. Ann Rheum Dis. 2007. PMID: 16793840 Free PMC article.

5

Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis.

Wolbink GJ, Vis M, Lems W, Voskuyl AE, de Groot E, Nurmohamed MT, Stapel S, Tak PP, Aarden L, Dijkmans B. Wolbink GJ, et al. Arthritis Rheum. 2006 Mar;54(3):711-5. doi: 10.1002/art.21671. Arthritis Rheum. 2006. PMID: 16508927 Free article.

6

4-Hydroxy-oxyphenbutazone is a potent inhibitor of cytokine production.

Ten Brinke A, Dekkers DW, Notten SM, Karsten ML, de Groot ER, Aarden LA. Ten Brinke A, et al. Among authors: de groot er. Eur Cytokine Netw. 2005 Jun;16(2):144-51. Eur Cytokine Netw. 2005. PMID: 15941686 Free article.

7

Potentiation of Toll-like receptor-induced cytokine production by (1-->3)-beta-D-glucans: implications for the monocyte activation test.

Kikkert R, Bulder I, de Groot ER, Aarden LA, Finkelman MA. Kikkert R, et al. Among authors: de groot er. J Endotoxin Res. 2007;13(3):140-9. doi: 10.1177/0968051907080024. J Endotoxin Res. 2007. PMID: 17621556

8

Cytokine induction by pyrogens: comparison of whole blood, mononuclear cells, and TLR-transfectants.

Kikkert R, de Groot ER, Aarden LA. Kikkert R, et al. Among authors: de groot er. J Immunol Methods. 2008 Jul 20;336(1):45-55. doi: 10.1016/j.jim.2008.03.010. Epub 2008 Apr 22. J Immunol Methods. 2008. PMID: 18456276

9

Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis.

Wolbink GJ, Voskuyl AE, Lems WF, de Groot E, Nurmohamed MT, Tak PP, Dijkmans BA, Aarden L. Wolbink GJ, et al. Ann Rheum Dis. 2005 May;64(5):704-7. doi: 10.1136/ard.2004.030452. Epub 2004 Oct 14. Ann Rheum Dis. 2005. PMID: 15485995 Free PMC article.

10

Induction of T cell proliferation with anti-CD3 switch-variant monoclonal antibodies: effects of heavy chain isotype in monocyte-dependent systems.

Van Lier RA, Boot JH, De Groot ER, Aarden LA. Van Lier RA, et al. Among authors: de groot er. Eur J Immunol. 1987 Nov;17(11):1599-604. doi: 10.1002/eji.1830171112. Eur J Immunol. 1987. PMID: 2960543

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

65 results

Search Page